Last reviewed · How we verify
NCT01299675
SureScan Post-Approval Study
trial in Bradycardia in 2,483 participants. Completed in 2 October 2017.
2 October 2017
Quick facts
| Lead sponsor | Medtronic |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 2,483 |
| Start date | 8 February 2011 |
| Primary completion | 2 October 2017 |
| Estimated completion | 2 October 2017 |
| Sites | 61 locations across Canada, United States |
Conditions studied
- Bradycardia — all drugs for Bradycardia →
Sponsor
Medtronic — full company profile →
Who can join
Eligibility, any sex, with Bradycardia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this Post-Approval Study (PAS) is to demonstrate the chronic performance of the SureScan pacing system when used in an MRI environment according to product labeling. This study is required by the Food and Drug Administration (FDA) as a condition of product approval.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Real-World Evaluation of Magnetic Resonance Imaging in Patients With a Magnetic Resonance Imaging Conditional Pacemaker System: Results of 4-Year Prospective Follow-Up in 2,629 Patients.
Williamson BD, Gohn DC, Ramza BM, Singh B, et al · · 2017 · cited 19× · PMID 29759618 · DOI 10.1016/j.jacep.2017.05.011
Verify or expand the search:
- PubMed search for NCT01299675
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bradycardia
Currently open trials in the same condition.
- NCT07209852 — Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up · recruiting
- NCT07254013 — Left Bundle Branch Area Pacing (LBBAP) Monitoring Assistant: Evaluation of Portable ECG Solution · NA · recruiting
- NCT07166614 — Dexmedetomidine vs Propofol in High-Risk ERCP Patients · NA · recruiting
- NCT07585799 — Permanent Conduction System Pacing Versus Atrioventricular Management for Patients With Wide QRS and Patent AV Conductio · NA · recruiting
- NCT07217392 — Left Bundle Branch Area Pacing (LBBAP) PMCF Study · NA · recruiting
Other Medtronic trials
Trials by the same sponsor.
- NCT07507422 — Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation Th · not yet recruiting
- NCT06637995 — Product Surveillance Registry; Ear, Nose &Amp; Throat - NIM Vital Cohort · completed
- NCT06048731 — Enlighten Study: The EV-ICD Post Approval Registry · active not recruiting
- NCT05925985 — Propel Drug-Eluting Sinus Stent Family Open Cohort · completed
- NCT05095935 — Medtronic Signia SDR Product Surveillance Registry · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01299675 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medtronic
- Last refreshed: 27 April 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01299675.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing